(Q43600777)

English

Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Matsuo K

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Takenaka K

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Shimomura H

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Fujii N

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Shinagawa K

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kiura K

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Harada M

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

191-195

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057970

21 January 2018

Identifiers

10.3109/10428190109057970

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43600777&oldid=2101818883"